UBS Group AG - FIRST WAVE BIOPHARMA INC ownership

FIRST WAVE BIOPHARMA INC's ticker is and the CUSIP is 33749P200. A total of 14 filers reported holding FIRST WAVE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of FIRST WAVE BIOPHARMA INC
ValueSharesWeighting
Q4 2022$12,552
+318.4%
14,264
+613.2%
0.00%
Q3 2022$3,0002,0000.00%
Other shareholders
FIRST WAVE BIOPHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 12,628$19,0000.00%
Kathleen S. Wright Associates Inc. 155$00.00%
ROYAL BANK OF CANADA 1$00.00%
JANE STREET GROUP, LLC 10,409$15,0000.00%
UBS Group AG 2,000$3,0000.00%
US BANCORP \DE\ 170$00.00%
BANK OF AMERICA CORP /DE/ 8$00.00%
FIRST MANHATTAN CO. LLC. 8$00.00%
WELLS FARGO & COMPANY/MN 196$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of FIRST WAVE BIOPHARMA INC shareholders